Twelve months after releasing a roadmap to shift away from animal testing requirements, the FDA has declared mission ...
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological products and drugs, instead moving toward alternative testing models such ...
Every year, millions of animals are used in laboratories, and for many people, the image is immediate and uncomfortable: ...
New grants support organoids, organs-on-chips, and in silico approaches to reduce reliance on animal models, but experts say ...
If non-animal testing models like organoids are used correctly, experts note they can cut failure rates and facilitate ...
Merck KGaA plans to phase out most animal testing in favor of new approach methodologies (NAMs) such as organs-on-a-chip and organoids over the next decade. The move aligns with a global regulatory ...
When we imagine the process of developing new drugs, we often picture scientists working with cutting-edge technology in gleaming laboratories. But there’s a side of pharmaceutical research that is ...
In recent months, the Food and Drug Administration and National Institutes of Health have announced new initiatives to reduce and replace animal testing in biomedical research. Central to these ...
When developing new therapies for diseases, biotech researchers are often limited by two time-consuming steps: first, screening thousands of drug candidates in test tubes and second, taking the best ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results